How exercise and a specific medication affect blood flow and insulin function in muscles
Effects of Exercise and GLP-1R Agonism on Muscle Microvascular Perfusion and Insulin Action
This study is looking at how exercise and a specific medication can help improve blood flow and insulin function in people with metabolic syndrome, to see if doing both together works better than just one on its own.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-10833561 on NIH RePORTER |
What this research studies
This research investigates how physical activity and glucagon-like peptide 1 (GLP-1) receptor agonists can improve blood flow and insulin action in muscles for individuals with metabolic syndrome. The study aims to understand the mechanisms behind these effects, particularly focusing on how they enhance microvascular perfusion and muscle angiogenesis. By using advanced techniques like contrast-enhanced ultrasound, researchers will assess the impact of these interventions on insulin resistance in patients. The goal is to determine if combining exercise with GLP-1 receptor agonism provides greater benefits than either approach alone.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with metabolic syndrome who are experiencing insulin resistance.
Not a fit: Patients without metabolic syndrome or those who do not have insulin resistance may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for individuals with metabolic syndrome, potentially reducing their risk of developing type 2 diabetes and cardiovascular diseases.
How similar studies have performed: Previous research has shown that both exercise and GLP-1 receptor agonists can positively impact metabolic health, suggesting that this combined approach may also be effective.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Liu, Zhenqi — University of Virginia
- Study coordinator: Liu, Zhenqi
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.